Literature DB >> 31965318

Quality of life effects of pain from para-lumbar- and lower extremity entrapment syndrome and carpal tunnel syndrome and comparison of the effectiveness of surgery.

Rinko Kokubo1, Kyongsong Kim2, Toyohiko Isu3, Daijiro Morimoto4, Naotaka Iwamoto4, Akio Morita4.   

Abstract

INTRODUCTION: We compared the preoperative quality of life (QOL) of patients with carpal tunnel syndrome, lower extremity-, and para-lumbar entrapment syndrome, and the effect of surgery on their QOL. PATIENTS AND METHODS: We prospectively enrolled 66 consecutive patients who underwent surgery for carpal tunnel syndrome (group 1, n = 23), lower extremity entrapment syndrome (group 2, n = 22), and para-lumbar entrapment syndrome (group 3, n = 21). Their pre- and postoperative overall health status was assessed on the Medical Outcomes Study Short-Form 36 Health Survey, v2 (SF-36).
RESULTS: Except for the mental component summary, the preoperative score for items rated on the SF-36 was significantly lower in group 3 than in groups 1 and 2 (p < 0.05). In all 66 patients, the scores for bodily pain (BP) and the physical component summary (PCS) were significantly lower (p < 0.05) than the national standard, as was the score for physical functioning (PF) in groups 2 and 3. After surgery, PF of group 2 and PF, BP, and PCS of group 3 improved significantly (p < 0.05).
CONCLUSION: The detrimental QOL effects are stronger in patients with para-lumbar- or lower extremity entrapment syndrome than in patients with carpal tunnel syndrome.

Entities:  

Keywords:  Entrapment neuropathy; Para-lumbar entrapment syndrome; Peripheral nerve; Quality of life; SF-36s

Mesh:

Year:  2020        PMID: 31965318     DOI: 10.1007/s00701-020-04226-8

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  1 in total

1.  Perioperative Complications and Adverse Events after Surgery for Peripheral Nerve- and Para-lumbar Spine Diseases.

Authors:  Kyongsong Kim; Toyohiko Isu; Daijiro Morimoto; Rinko Kokubo; Fumiaki Fujihara; Akio Morita
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-11-10       Impact factor: 1.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.